ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
STRM.BIO
STRM.BIOSTRM.BIO is a biotech startup focused on developing a gene therapy delivery platform utilizing extracellular vesicles. They aim to create targeted, scalable, and low-immunogenicity genetic medicines, primarily targeting the bone marrow.
Headquarters
Boston, Massachusetts, United States
Company Size
11-50 employees
Founded
2019
STRM.BIO is a biotechnology company focused on expanding the possibilities of in vivo gene therapy through its proprietary megakaryocyte-derived extracellular vesicle (STRM MV) platform, which enables safe, scalable, non-viral delivery of complex genetic medicines to bone marrow. The platform supports gene editing, RNA therapeutics, and immune cell engineering with an initial focus on rare hematological diseases and CAR-T therapies. STRM.BIO works to remove the delivery constraints of viral and synthetic systems, allowing therapies to be designed around disease biology rather than delivery tradeoffs.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for STRM.BIO.
11% below the average for this role
Associate Scientist - Regeneron Genetic Medicine
Regeneron Pharmaceuticals
Discovery Oncology Scientific Lead
Eli Lilly and Company
Graduate Research Appointment Wangensteen Lab Rochester Mn United States
Charterhouse
Senior Scientist Vector Engineering
AstraZeneca
Co-op: Screening & On-target NG
Prime Medicine
Research Officer
The Kids Research Institute Australia